LYTIR

Company · INCY

Incyte Corporation

Name as listed on its exchange; filed with the SEC as INCYTE CORP.

Nasdaq's symbol directory lists INCY on Nasdaq as “Incyte Corporation - Common Stock”.

In the 12 months to Nov 8, 2026: insiders sold on 14 occasions ($18.8M); 14 planned-sale notices; 5 company reports (Form 8-K, since May 26, 2026).

All insider filings at the SEC · Appeared in No. 35

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $18.8M in total.Jun: Insider sales $264KJul: Insider sales $10.4MAug: Insider sales $5.0MSep: Insider sales $2.8MOct: Insider sales $298KNov: Insider sales $73KDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $0Insider sales below: $18.8M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. CAGNONI PABLO J, President, Global Head of R&D sold on 6 days all under a 10b5-1 plan latest Oct 15, 2026 sold $9.0M
  2. Mayes Patrick A, EVP & Chief Scientific Officer sold on 3 days all under a 10b5-1 plan latest Aug 5, 2026 sold $6.0M
  3. Stein Steven H, CMO & Head of Late-Stage Dev. sold on 2 days all under a 10b5-1 plan latest Jul 16, 2026 sold $3.4M
  4. Tray Thomas, Principal Accounting Officer sold on 2 days all under a 10b5-1 plan latest Nov 3, 2026 sold $336K
  5. Issa Mohamed Khairie, EVP, Head of U.S. Commercial sold on 1 day all under a 10b5-1 plan latest Jul 16, 2026 sold $126K
Every trade (14)
  1. SELLTray Thomas, Principal Accounting Officer sold Nov 3, 2026 610 shares 10b5-1 plan (scheduled) filing $73K
  2. SELLCAGNONI PABLO J, President, Global Head of R&D sold Oct 15, 2026 2,642 shares 10b5-1 plan (scheduled) filing $298K
  3. SELLCAGNONI PABLO J, President, Global Head of R&D sold Sep 15, 2026 23,218 shares 2 legs combined 10b5-1 plan (scheduled) filing $2.8M
  4. SELLCAGNONI PABLO J, President, Global Head of R&D sold Aug 19, 2026 10,801 shares 10b5-1 plan (scheduled) filing $1.4M
  5. SELLCAGNONI PABLO J, President, Global Head of R&D sold Aug 12, 2026 10,803 shares 10b5-1 plan (scheduled) filing $1.3M
  6. SELLCAGNONI PABLO J, President, Global Head of R&D sold Aug 5, 2026 10,640 shares 10b5-1 plan (scheduled) filing $1.3M
  7. SELLMayes Patrick A, EVP & Chief Scientific Officer sold Aug 5, 2026 2,207 shares 10b5-1 plan (scheduled) filing $274K
  8. SELLMayes Patrick A, EVP & Chief Scientific Officer sold Aug 3, 2026 6,055 shares 10b5-1 plan (scheduled) filing $729K
  9. SELLMayes Patrick A, EVP & Chief Scientific Officer sold Jul 31, 2026 41,899 shares 11 legs combined 10b5-1 plan (scheduled) filing $5.0M
  10. SELLCAGNONI PABLO J, President, Global Head of R&D sold Jul 31, 2026 15,888 shares 10b5-1 plan (scheduled) filing $1.9M
  11. SELLStein Steven H, CMO & Head of Late-Stage Dev. sold Jul 16, 2026 1,877 shares 10b5-1 plan (scheduled) filing $215K
  12. SELLIssa Mohamed Khairie, EVP, Head of U.S. Commercial sold Jul 16, 2026 1,093 shares 10b5-1 plan (scheduled) filing $126K
  13. SELLStein Steven H, CMO & Head of Late-Stage Dev. sold Jul 15, 2026 28,237 shares 10b5-1 plan (scheduled) filing $3.2M
  14. SELLTray Thomas, Principal Accounting Officer sold Jun 4, 2026 2,639 shares 10b5-1 plan (scheduled) filing $264K

Planned sales · SEC Form 144

Notice given

A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Every recent notice

  1. STEVEN STEIN filed Nov 6, 2026 Officer 240,193 shares planned sale date 11/06/2026 filing $28.3M
  2. THOMAS TRAY filed Nov 3, 2026 Officer 610 shares planned sale date 11/03/2026 filing $73K
  3. PABLO CAGNONI filed Oct 15, 2026 Officer 2,642 shares planned sale date 10/15/2026 filing $298K
  4. PABLO CAGNONI filed Sep 15, 2026 Officer 23,218 shares planned sale date 09/15/2026 filing $2.8M
  5. PABLO CAGNONI filed Aug 19, 2026 Officer 10,801 shares planned sale date 08/19/2026 filing $1.4M
  6. PABLO CAGNONI filed Aug 12, 2026 Officer 10,803 shares planned sale date 08/12/2026 filing $1.3M
  7. PABLO CAGNONI filed Aug 5, 2026 Officer 10,640 shares planned sale date 08/05/2026 filing $1.3M
  8. PATRICK A MAYES filed Aug 5, 2026 Officer 2,207 shares planned sale date 08/05/2026 filing $274K
  9. PATRICK A MAYES filed Aug 3, 2026 Officer 6,055 shares planned sale date 08/03/2026 filing $729K
  10. PATRICK A MAYES filed Jul 31, 2026 Officer 41,899 shares planned sale date 07/31/2026 filing $5.0M
  11. PABLO CAGNONI filed Jul 31, 2026 Officer 15,888 shares planned sale date 07/31/2026 filing $1.9M
  12. STEVEN STEIN filed Jul 16, 2026 Officer 1,877 shares planned sale date 07/16/2026 filing $215K
  13. MOHAMED ISSA filed Jul 16, 2026 Officer 1,093 shares planned sale date 07/16/2026 filing $126K
  14. STEVEN STEIN filed Jul 15, 2026 Officer 28,237 shares planned sale date 07/15/2026 filing $3.2M

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Results of operations and financial condition filing Oct 29, 2026
  2. Other events filing Aug 31, 2026
  3. Results of operations and financial condition filing Jul 28, 2026
  4. Other events filing Jul 6, 2026
  5. Other events filing Jun 22, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.